| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 07/16/2003 | EP1326612A1 Gatifloxacin pentahydrate |
| 07/16/2003 | EP0787720B1 Pyridonecarboxylate derivative or salt thereof and antibacterial containing the same as active ingredient |
| 07/16/2003 | CN1430607A Benzophenones as inhibitors of IL-1 beta and TNF-alpha |
| 07/16/2003 | CN1430602A Ary-and heteroaryl sulfonates compounds |
| 07/16/2003 | CN1430596A New gamma selective retinoids |
| 07/16/2003 | CN1114608C Novel camptothecine analogues, prepn. method therefor, use thereof, and pharmaceutical compositions contg. same |
| 07/16/2003 | CN1114597C Quinoline derivs |
| 07/16/2003 | CN1114407C Use of chelating agent clioquinol for manufacture of pharmaceutical compsn. for treatment of alzheimer's disease |
| 07/15/2003 | US6593343 Antiinflammatory agents; autoimmune diseases |
| 07/15/2003 | US6593342 Pharmaceutical compositions comprising 2-quinolones |
| 07/15/2003 | US6593335 Disease than can be ameliorated with a potassium channel opener in a host mammal, comprising administering to the mammal in need thereof a therapeutically effective amount of the compound of claim 1; said disease is epilepsy, Raynaud's |
| 07/15/2003 | US6593327 Compounds and compositions as protease inhibitors |
| 07/15/2003 | US6593324 Dervatives of quinoline as alpha-2 antagonists |
| 07/10/2003 | WO2003055866A1 Quinazoline and quinoline derivative compounds as inhibitors of prolylpeptidase, inducers of apoptosis and cancer treatment agents |
| 07/10/2003 | WO2003055850A1 β-AMYLOID PROTEIN PRODUCTION/SECRETION INHIBITORS |
| 07/10/2003 | WO2003055848A2 Urea derivatives as vr1- antagonists |
| 07/10/2003 | WO2003055843A1 Agaricoglycerides and analogs |
| 07/10/2003 | WO2003055478A1 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders |
| 07/10/2003 | WO2001096297A3 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 07/10/2003 | US20030130505 Nonsteroidal agonists and antagonists |
| 07/10/2003 | US20030130295 Substituted 2-aminoacetamides and the use thereof |
| 07/10/2003 | US20030130287 Psychological disorders; central nervous system disorders; antidepressants; Parkinson's disease; Alzheimer's disease;cardiovascular disorders |
| 07/10/2003 | US20030130285 Controlling cell differentiation, cell proliferation |
| 07/10/2003 | US20030130125 Pesticides; herbicides |
| 07/10/2003 | US20030129670 Using hydrophobic fluorescent ion capable of redistributing from a first face of the membrane to a second face of the membrane in response to changes in the membrane potential |
| 07/10/2003 | US20030129552 Color photothermography |
| 07/10/2003 | CA2469967A1 Urea derivatives as vr1- antagonists |
| 07/09/2003 | EP1325914A1 Tetrahydroquinoline compounds |
| 07/09/2003 | EP1325912A1 2,2-diphenylbutanamide derivatives and medicines containing the same |
| 07/09/2003 | EP1325745A1 Preventives and remedies for complications of diabetes |
| 07/09/2003 | EP1324986A1 Nitrogen-containing compounds and their use as glycine transport inhibitors |
| 07/09/2003 | EP0983262B1 Quinoline-4-carboxamide derivatives as nk-2 and nk-3 receptor antagonists |
| 07/09/2003 | CN1429198A Novel phenyl-proparylether derivatives |
| 07/09/2003 | CN1429126A Use of cyanoquinolines for treating or inhibiting colonic polyps |
| 07/09/2003 | CN1428335A Preparation method of Menlust sodium and its preparation intermediate |
| 07/09/2003 | CN1428145A Quinoline derivative as tachykinin NK3 receptor agonist |
| 07/09/2003 | CN1113881C 8-substituted-1,3,8-triaza-spiro [4.5] decan-4-on derivatives |
| 07/08/2003 | US6590101 Hydrolysis of the corresponding C1-C4-alkyl esters with addition of water, acetic acid, and sulfuric acid using a drastically reduced amount of sulfuric acid |
| 07/08/2003 | US6589966 A family of hexadentate Fe(II) chelators having marked antiproliferative activity against tumor cells is disclosed. The cytotoxic metal chelators and complexes of the present invention are represented by the general formula below: |
| 07/08/2003 | US6589955 Pediatric formulation of gatifloxacin |
| 07/08/2003 | US6589504 Binding or aggregating fibrils with radiolabeled quinoline-hydrazone compound |
| 07/08/2003 | CA2278845C Process for preparing quinolone and naphthyridone carboxylic acids |
| 07/08/2003 | CA2272640C Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists |
| 07/03/2003 | WO2003053980A1 Rare earth metal compounds and mixtures of these |
| 07/03/2003 | WO2003053971A1 Pyridoquinoxaline antivirals |
| 07/03/2003 | WO2003053969A1 Imidazoquinoline derivatives |
| 07/03/2003 | WO2003053968A1 Triazolo-quinolin derivatives useful as adenosine receptor ligands |
| 07/03/2003 | WO2003053945A2 Urea derivatives and their use as vanilloid receptor antagonists |
| 07/03/2003 | WO2003053926A1 Novel phenylalanine derivative |
| 07/03/2003 | WO2003053915A2 Compounds for the treatment of inflammatory disorders |
| 07/03/2003 | WO2003053912A1 α-(N-SULPHONAMIDO)ACETAMIDE DERIVATIVES AS β-AMYLOID INHIBITORS |
| 07/03/2003 | US20030125355 Processes for preparing quinoline derivatives and intermedias thereof |
| 07/03/2003 | US20030125354 Aromatic compounds containing urea or thiourea groups are useful for terating cytokine mediated diseases |
| 07/03/2003 | US20030125337 Enhancing the antibacterial action of fluoroquinolones by contacting a bacterium with an indole, a urea, an aromatic amide or a quinoline |
| 07/03/2003 | CA2471089A1 Pyridoquinoxaline antivirals |
| 07/02/2003 | EP1322651A1 Bicyclic heteroaromatic compounds |
| 07/02/2003 | EP1322631A2 Methods of providing and using compounds ( retinoids ) having activity as inhibitors of cytochrome p450rai |
| 07/02/2003 | EP1322618A1 Amino heterocyclic compounds (factor x a? inhibitors 14) |
| 07/02/2003 | EP1322615A2 Fluorinated quinolones as antimitotic and antitumor agents |
| 07/02/2003 | EP1322598A1 Nitroso diphenylamine derivatives |
| 07/02/2003 | EP1322583A1 Method for the isomerisation of allyl alcohols |
| 07/02/2003 | EP1322309A2 High affinity small molecule c5a receptor modulators |
| 07/02/2003 | EP0990647B1 Process for producing quinolone derivatives |
| 07/02/2003 | EP0944582B1 Ketobenzamides as calpain inhibitors |
| 07/02/2003 | EP0782986B1 Novel heterocyclic derivatives, process for producing the same, and medicinal use thereof |
| 07/02/2003 | CN1427721A Peptide deformylase inhibitors |
| 07/02/2003 | CN1427718A Pharmaceutical compounds for treating COPD |
| 07/02/2003 | CN1427001A Preparation method of organic electro luminous material 8-hydroxy quinoline aluminium |
| 07/02/2003 | CN1113057C Quinoline derivatives |
| 07/01/2003 | US6586466 Carbohydrazide-protease inhibitors |
| 07/01/2003 | US6586448 Cholesteryl ester transfer protein inhibitors used as antilipemic agents for prophylaxis of cardiovascular disorders |
| 06/26/2003 | WO2003051878A1 Quinolinones as prostaglandin receptor ligands |
| 06/26/2003 | WO2003051872A1 Ethylene diamine derivatives and their use as orexin-receptor antagonists |
| 06/26/2003 | WO2003051844A1 2,3-dihydro-1h-quinolin-4-one oxime derivative and inhibitors of the induction of heat shock protein expression |
| 06/26/2003 | WO2003051842A2 Compositions decreasing activity of hormone-sensitive lipase |
| 06/26/2003 | WO2003051841A2 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 06/26/2003 | US20030120075 Stereospecific enrichment of heterocyclic enantiomers |
| 06/26/2003 | US20030119876 Compounds for the treatment of protozoal diseases |
| 06/26/2003 | US20030119863 4-Quinolinol derivatives and agrohorticultural bactericides containing the same as active ingredient |
| 06/26/2003 | US20030119855 Heterocycle derivatives and drugs |
| 06/26/2003 | US20030119848 A oxoquinolines or a 4-oxo-1,8-naphthyridines or 7-oxo-7H-pyrido(1,2,3-de)(1,4)benzoxazine derivative for the treatment of tuberculosis, exhibits no cross resistance |
| 06/26/2003 | US20030119845 4-((4-benzyl(or methyl heteroaryl)-,1-piperazinyl)(8-quinolinyl)methyl)-N,N-diethylbenzamide or salt, useful for pain treatment |
| 06/26/2003 | US20030119843 Tricycloheteroaromic ring containing imidazole compounds used as farnesyl transferase and geranylgeranyl transferase inhibitor |
| 06/26/2003 | US20030119827 Peptidyl carbamates; treatments for osteoporosis and autoimmune diseases |
| 06/26/2003 | US20030119818 CRF antagonistic quino-and quinazolines |
| 06/26/2003 | US20030119791 Binding to nuclear receptor proteins; stimulating BMP-2 promoter activity |
| 06/26/2003 | US20030119788 N-cyanomethyl carbonamides and sulfonamides which are cysteine protease, particularly cathepsin K, inhibitors |
| 06/26/2003 | CA2469048A1 Quinolinones as prostaglandin receptor ligands |
| 06/26/2003 | CA2468413A1 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 06/25/2003 | EP1320523A2 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases |
| 06/25/2003 | EP1320520A1 Sulfonylguanidine |
| 06/25/2003 | EP1244650B1 Arylamine derivatives and their use as anti-telomerase agent |
| 06/25/2003 | EP1025086B1 Benzamidine derivatives as factor xa inhibitors |
| 06/25/2003 | EP0906094B1 Substituted n- (aminoiminomethyl or aminomethyl)phenyl]propyl amides |
| 06/25/2003 | CN1426410A Dual molecules containing peroxide derivative; synthesis and therapeutic applications thereof |
| 06/25/2003 | CN1426399A Process for producing quinolonecarboxylic acids and intermediates thereof |
| 06/25/2003 | CN1426396A Substituted benzoic acid amides and use for inhibition of angiogenesis thereof |
| 06/25/2003 | CN1426391A Polyamine analogues as cytotoxic agents |
| 06/24/2003 | US6583299 α-amino-β-sulfonyl hydroxamic acid compounds |
| 06/24/2003 | US6583286 Method for hydrogenating unsaturated heterocyclic compounds |